Organization · Venture Capital
MIG Capital
MIG Capital is a Munich-based venture capital firm that invests in early-stage companies in the life sciences and deep tech sectors across Europe. Founded in 2004, it has a unique funding model supported by over 60,000 private retail investors.
Overview
What MIG Capital does
What MIG Capital is
MIG Capital is a Munich-based venture capital firm that invests in early-stage companies in the life sciences and deep tech sectors across Europe. Founded in 2004, it has a unique funding model supported by over 60,000 private retail investors.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2004
- Approximate age
- About 22 years
- Structured capabilities
- Funder
- Last reviewed
- March 17, 2026
Official channels
Find MIG Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
MIG Capital as a funder
Investment thesis
MIG Capital focuses on investing in deep tech and life sciences, supporting innovative companies with both capital and personal networks.
Focus narrative
MIG Capital invests primarily in deep tech and life sciences. In deep tech, the firm focuses on advanced computing, digitalization & IoT, energy & environment, and new materials. In life sciences, it covers bio-pharmaceutical therapeutics, medical technology, and digital health. The firm typically invests between €1 million and €10 million, with a sweet spot around €3 million to €5 million.
Value beyond capital
MIG Capital adds value to its portfolio companies by providing not just financial investment but also personal support and access to a vast network of industry contacts. This approach helps companies navigate challenges and accelerate their growth.
Terms and economics
- Typical check
- $1,000,000–$10,000,000
- Sweet spot
- $5,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A · Series B · Growth Equity
- Regions
- Europe · Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 50
- Recorded notable exits
- BioNTech, Siltectra, Hemovent, BRAIN, NFON, and Immatics
Portfolio context
MIG Capital's portfolio includes notable companies such as Wealthpilot, a SaaS platform for hybrid wealth management; BioNTech, a pioneering biotechnology company known for its mRNA technology; AirID, which focuses on secure authentication solutions; Astra Therapeutics, a biotech firm that received seed financing; and CoreMedic, involved in medical technology.
Common questions
What to know about MIG Capital
Upseed classifies MIG Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 17, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.